Karim Pirani

Director, Business Development

Eastern USA

(978) 831-8858

Karim.Pirani@pfanstiehl.com

Chandra Kelley

Director, Business Development

Western USA

(951) 331-9913

Chandra.Kelley@pfanstiehl.com

Christian Lotz

Director, Business Development

Europe, Middle East, Africa

+41 79 699 94 96

Christian.Lotz@pfanstiehl.com


Jagdish Kuchibhatla

Vice President, Sales & Marketing

Asia Pacific

+65-91076235

Jagdish.Kuchibhatlas@pfanstiehl.com

Customer Service

Global

+847 623-0370

cs@pfanstiehl.com

Go to article: Home | Cracking Alzheimer'sGo to article: In This IssueGo to article: Scandinavian Healthcare Limited Company InsightGo to article: Scandinavian Healthcare LimitedGo to article: ContentsGo to article: DJAGo to article: NewsGo to article: Where are the world's pharma manufacturing hotspots?Go to article: Bea TechnologiesGo to article: Cracking the mystery of Alzheimer's diseaseGo to article: Is a universal flu vaccine on horizon?Go to article: MicronovaGo to article: The racemisation risk: new tool could identify drugs destined to failGo to article: BioassayGo to article: Shooting up: what does the future hold for growth drugs?Go to article: Gerteis Company InsightGo to article: GerteisGo to article: Could a new antibody screening method lead to better drugs?Go to article: AlpexGo to article: EventsGo to article: Event: CPhI ChinaGo to article: AbiogenGo to article: Next IssueGo to article: MoehsGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Novo NordiskGo to article: Pharma Support ServicesGo to article: CyberfreightGo to article: SmartCAE Company InsightGo to article: SmartCAEGo to article: Brooks Automation IncGo to article: EcocoolGo to article: ZenatekGo to article: Miami International AirportGo to article: AirBridgeCargoGo to article: AirBridgeCargo Company InsightGo to article: SkycellGo to article: G.F.Go to article: BaxterGo to article: BrukerGo to article: EmisphereGo to article: SephaGo to article: raPHARMGo to article: Sanofi